ATE326969T1 - Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation - Google Patents
Verwendung von apomorphin zur behandlung der vorzeitigen ejakulationInfo
- Publication number
- ATE326969T1 ATE326969T1 AT99923347T AT99923347T ATE326969T1 AT E326969 T1 ATE326969 T1 AT E326969T1 AT 99923347 T AT99923347 T AT 99923347T AT 99923347 T AT99923347 T AT 99923347T AT E326969 T1 ATE326969 T1 AT E326969T1
- Authority
- AT
- Austria
- Prior art keywords
- apomorphine
- premature ejaculation
- treat premature
- treat
- ejaculation
- Prior art date
Links
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 title 1
- 229960004046 apomorphine Drugs 0.000 title 1
- 206010036596 premature ejaculation Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/086,630 US6403605B1 (en) | 1998-05-29 | 1998-05-29 | Methods for the normalization of sexual response and amelioration of long term genital tissue degradation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE326969T1 true ATE326969T1 (de) | 2006-06-15 |
Family
ID=22199842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99923347T ATE326969T1 (de) | 1998-05-29 | 1999-05-28 | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US6403605B1 (de) |
| EP (2) | EP1666040A1 (de) |
| AR (1) | AR019579A1 (de) |
| AT (1) | ATE326969T1 (de) |
| AU (1) | AU764009B2 (de) |
| CA (1) | CA2331387A1 (de) |
| DE (1) | DE69931487T2 (de) |
| ES (1) | ES2268869T3 (de) |
| TW (1) | TWI232748B (de) |
| WO (1) | WO1999062502A2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395744B1 (en) | 1994-04-22 | 2002-05-28 | Queen's University At Kingston | Method and compositions for the treatment or amelioration of female sexual dysfunction |
| SE0002934D0 (sv) | 2000-08-17 | 2000-08-17 | Axon Biochemicals Bv | New aporphine esters and in their use in therapy |
| SE0102036D0 (sv) * | 2001-06-08 | 2001-06-08 | Axon Biochemicals Bv | Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof |
| RU2364400C2 (ru) * | 2003-04-14 | 2009-08-20 | Вектура Лтд | Фармацевтические композиции |
| US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
| US20050181057A1 (en) * | 2004-02-13 | 2005-08-18 | Rosenberg Paul K. | Vaginal lubricant |
| SI1750766T1 (sl) | 2004-05-11 | 2013-11-29 | Emotional Brain B.V. | Farmacevtske formulacije in njihove uporabe pri zdravljenju spolne disfunkcije pri Ĺľenskah |
| EP1790343A1 (de) | 2005-11-11 | 2007-05-30 | Emotional Brain B.V. | Pharmazeutische Zusammensetzungen und deren Verwendung zur Behandlung sexueller Störungen der Frau |
| EP1925307A1 (de) | 2006-11-03 | 2008-05-28 | Emotional Brain B.V. | Verwendung von 3-alpha-androstanediol zur Behandlung sexueller Dysfunktion |
| CN101674728A (zh) * | 2007-02-12 | 2010-03-17 | Dmi生物科学公司 | 降低曲马多的副作用 |
| CN101657101B (zh) * | 2007-02-12 | 2013-12-11 | Dmi生物科学公司 | 并存早泄和勃起功能障碍的治疗 |
| WO2010022326A2 (en) * | 2008-08-22 | 2010-02-25 | Us Worldmeds Llc | Transdermal delivery of apomorphine using microneedles |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2818855A (en) | 1954-02-11 | 1958-01-07 | Anthony P Miller | Surgical device |
| US4127118B1 (en) | 1977-03-16 | 1995-12-19 | Alvaro Latorre | Method of effecting and enhancing an erection |
| US4543256A (en) | 1982-03-17 | 1985-09-24 | Northeastern University | (-)-10,1L Methylenedioxy-N-N-propylnoraporphine and methods employing it for inhibiting the effects of epileptic seizures and for prevention and treatment of duodenal ulcers |
| US4687773A (en) | 1983-03-28 | 1987-08-18 | Mclean Hospital | (+)-N-N-propylnorapomorphine and selective limbic activity |
| US4521421A (en) | 1983-09-26 | 1985-06-04 | Eli Lilly And Company | Treatment of sexual dysfunction |
| US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| US4640921A (en) | 1986-02-04 | 1987-02-03 | Bristol-Myers | Treatment of sexual dysfunction with buspirone |
| US4801587A (en) | 1987-03-02 | 1989-01-31 | Gene Voss | Impotence ointment |
| US4980358A (en) * | 1988-04-04 | 1990-12-25 | George D. McAdory | Method employing gonadal hormones and dopamine agonist intended for combined use in the improvement of lymphocyte function |
| US5242391A (en) | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
| US5270323A (en) | 1990-05-31 | 1993-12-14 | Pfizer Inc. | Method of treating impotence |
| US5324718A (en) | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
| DE69434304T2 (de) | 1993-03-26 | 2005-12-29 | Merkus, Franciscus Wilhelmus H.M. | Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin |
| JP3310982B2 (ja) | 1994-04-22 | 2002-08-05 | ペンテツク・フアーマシユーテイカルズ・インコーポレイテツド | 男性の勃起機能不全を改善するための剤形及び方法 |
| EP0714663A3 (de) | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten |
| ATE362931T1 (de) | 1995-10-13 | 2007-06-15 | Neurosearch As | 8-azabicyclo(3.2.1)oct-2en-derivate, deren herstellung und anwendung |
-
1998
- 1998-05-29 US US09/086,630 patent/US6403605B1/en not_active Expired - Fee Related
-
1999
- 1999-05-27 AR ARP990102489A patent/AR019579A1/es unknown
- 1999-05-28 EP EP05025295A patent/EP1666040A1/de not_active Withdrawn
- 1999-05-28 CA CA002331387A patent/CA2331387A1/en not_active Abandoned
- 1999-05-28 AU AU40272/99A patent/AU764009B2/en not_active Ceased
- 1999-05-28 EP EP99923347A patent/EP1082118B1/de not_active Expired - Lifetime
- 1999-05-28 AT AT99923347T patent/ATE326969T1/de not_active IP Right Cessation
- 1999-05-28 WO PCT/CA1999/000508 patent/WO1999062502A2/en not_active Ceased
- 1999-05-28 DE DE69931487T patent/DE69931487T2/de not_active Expired - Fee Related
- 1999-05-28 ES ES99923347T patent/ES2268869T3/es not_active Expired - Lifetime
- 1999-07-07 TW TW088111525A patent/TWI232748B/zh not_active IP Right Cessation
-
2002
- 2002-05-20 US US10/147,904 patent/US20030092725A1/en not_active Abandoned
-
2006
- 2006-06-26 US US11/474,783 patent/US20060281752A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TWI232748B (en) | 2005-05-21 |
| AR019579A1 (es) | 2002-02-27 |
| WO1999062502A3 (en) | 2000-06-15 |
| EP1082118A2 (de) | 2001-03-14 |
| AU4027299A (en) | 1999-12-20 |
| WO1999062502A2 (en) | 1999-12-09 |
| CA2331387A1 (en) | 1999-12-09 |
| US20060281752A1 (en) | 2006-12-14 |
| ES2268869T3 (es) | 2007-03-16 |
| EP1082118B1 (de) | 2006-05-24 |
| US6403605B1 (en) | 2002-06-11 |
| DE69931487D1 (de) | 2006-06-29 |
| US20030092725A1 (en) | 2003-05-15 |
| HK1037517A1 (en) | 2002-02-15 |
| DE69931487T2 (de) | 2007-05-03 |
| AU764009B2 (en) | 2003-08-07 |
| EP1666040A1 (de) | 2006-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE365042T1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
| ATE288748T1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| ATE308364T1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| ATE401909T1 (de) | Verwendung von löslichen ctla4-mutanten zur behandlung von rheumatoider arthritis | |
| ATE179610T1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
| ATE247987T1 (de) | Behandlung zur beseitigung von gerüchen | |
| DE69724016D1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege | |
| ATE300597T1 (de) | Behandlung von geweben | |
| ATE353218T1 (de) | Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis | |
| ATE346614T1 (de) | Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung | |
| DE60015516D1 (de) | Verwendung von makroliden zur behandlung von trockenen augen | |
| ATE326969T1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
| ATE526982T1 (de) | Verwendung von neublastin-polypeptide zur behandlung von neuropathischen schmerzen | |
| DE69841984D1 (de) | Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen | |
| DE69625877D1 (de) | Verwendung von 5-HT1A Rezeptor-Liganden zur Behandlung des Glaukoms | |
| ATE339955T1 (de) | Verwendung von escitalopram zur behandlung von generalisierten angstzuständen | |
| ATE232378T1 (de) | Reinigungspflaster zur verbesserung des hautzustandes | |
| ATE218862T1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| ATE390474T1 (de) | Verwendung von polymerem material zur behandlung harter oberflächen | |
| ATE410181T1 (de) | Verwendung von intereferon gamma zur behandlung von herzhypertrophie | |
| DE69614264D1 (de) | Behandlung von aluminiumartikeln zur erhöhung der einbrennhärtbarkeit | |
| ATE209891T1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis | |
| ATE270102T1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |